CreditReports.dk
HomeScreen companies

Pharmaforce ApS Financials, key figures and credit report

CVR number: 26394198 Established 2001 Industry: 46 Wholesale trade
Company contact details
Frederiksborggade 15, 1360 København K tel: 70272747 www.pharmaforce.dk
Gross profit 5 238.5 kDKK FY 2025 -3.7% vs 2024
EBIT 1 171.2 kDKK FY 2025 -40.2% vs 2024
Net debt -3 135.5 kDKK FY 2025 -11.2% vs 2024
Quick ratio 2.6 FY 2025 +0.6 vs 2024

Company information

Official name
Pharmaforce ApS
Personnel
4 persons
Established
2001
Company form
Private limited company
Industry

Data sources and methodology

The information about Pharmaforce ApS combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.

Company information

Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).

CVR / Virk

Annual accounts

Financial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2025.

Open the 2025 annual report

Key figures and credit risk

Valuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.

Valuatum Oy

About Pharmaforce ApS

Pharmaforce ApS (CVR number: 2639419-8) is a company from KØBENHAVN. The company recorded a gross profit of 5238.5 kDKK in 2025. The operating profit was 1171.2 kDKK, while net earnings were 914.2 kDKK. The profitability of the company measured by Return on Assets (ROA) was 19.6 %, which can be considered excellent and Return on Equity (ROE) was 22.2 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 70.5 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. Pharmaforce ApS's liquidity measured by quick ratio was 2.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.

Financial information

See financials

Gross profit (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
2021
2022
2023
2024
2025
Volume
Net sales
Gross profit4 201.683 639.953 682.485 437.135 238.51
EBIT465.49424.60344.291 956.951 171.18
Net earnings367.49282.71262.221 494.36914.23
Shareholders equity total2 875.372 858.082 920.303 914.654 328.88
Balance sheet total (assets)6 776.245 634.634 786.606 169.256 573.34
Net debt979.69- 646.98-1 497.93-2 818.80-3 135.49
Profitability
EBIT-%
ROA8.2 %6.9 %7.4 %36.6 %19.6 %
ROE13.7 %9.9 %9.1 %43.7 %22.2 %
ROI13.8 %10.9 %12.9 %58.2 %30.1 %
Economic value added (EVA)214.3780.10109.441 357.30708.11
Solvency
Equity ratio42.4 %50.7 %61.0 %63.5 %70.5 %
Gearing68.8 %6.0 %1.0 %0.6 %0.8 %
Relative net indebtedness %
Liquidity
Quick ratio1.41.31.52.02.6
Current ratio1.82.02.62.72.9
Cash and cash equivalents999.37818.911 525.792 841.233 168.49
Capital use efficiency
Trade debtors turnover (days)
Net working capital %

Variable visualization

ROA FY 2025
19.6%
Rating 73/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio FY 2025
70.5%
Rating 53/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Credit Risk Report

Affordable credit risk report
for basic company risk checks.

Check the creditworthiness of Pharmaforce ApS before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.

AI Credit Risk Report

The core credit-risk figures,
explained with AI.

The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.

  1. 01 Includes the same financial figures, risk scores, credit rating and bankruptcy risk as the Credit Risk Report.
  2. 02 AI complements the analysis with web searches and brings in the relevant company and operating-environment observations.
  3. 03 The written analysis is more precise, more readable and better suited to decision-making.
€3 / report

Company-specific, AI-assisted credit risk report in PDF format.

For larger customers

Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk

The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.

What the report includes

8 sections
Financial figures
Risk scores
Credit rating
Bankruptcy risk
AI web-search highlights
Written risk analysis
Conclusions
Ratio appendices

Companies in the same industry

Page generated